Steroid receptors are important in the pathogenesis of a variety of disease states and modulate cellular processes through differential gene expression. Therefore, understanding the regulation of steroid receptors is essential. Environmental sodium arsenite, a toxin associated with male infertility, and arsenic trioxide, a possible prostate cancer therapeutic agent, are inorganic trivalent semimetals. The mechanism of arsenic action in male urogenital tract tissues is not clear. Since androgen receptor (AR) plays an important role in spermatogenesis and prostate cancer, we explored the possibility that trivalent arsenic regulates AR function. We found that arsenic inhibited AR transcriptional activity in prostate cancer and Sertoli cells by inhibiting AR recruitment to an AR target gene enhancer in vivo. Consistent with a deficiency in AR chromatin binding, arsenic disrupted AR amino and carboxyl-termini interaction. Furthermore, ATO caused a significant decrease in prostate cancer cell proliferation that was more pronounced in cells expressing AR compared to cells depleted of AR. Thus, arsenic-induced male infertility may be due to inhibition of AR activity and arsenic may serve as an effective therapeutic option in prostate cancer. Rac1, a Rho GTPase, modulates a variety of cellular processes and is hyperactive in cancer. Estrogen receptor (ER) regulates genes associated with cell proliferation, tumor development, and survival in breast cancer. Therefore, we examined the possibility of crosstalk between Rac1 and ER signaling. We found that Rac1 enhanced ER transcriptional activity in breast cancer cell lines. Vav3, a Rho guanine nucleotide exchange factor, was an upstream activator and P21/Cdc42/Rac1 activating kinase-1 (PAK-1) was a downstream effector of Rac1 enhancement of ER activity. These results suggest that Rac1 may be a beneficial therapeutic target. To test this hypothesis, we used EHT 1864, a small molecule Rac1 inhibitor. EHT 1864 inhibited ER transcriptional activity and estrogen-induced breast cancer cell proliferation. Furthermore, EHT 1864 inhibited ER activity by downregulation of ER mRNA and protein levels. Since ER plays a critical role in the pathogenesis of breast cancer and EHT 1864 inhibits ER activity and breast cancer cell proliferation, Rac1 inhibition is a novel and compelling therapeutic target in breast cancer.
| Identifer | oai:union.ndltd.org:UMIAMI/oai:scholarlyrepository.miami.edu:oa_dissertations-1273 |
| Date | 16 July 2009 |
| Creators | Rosenblatt, Adena |
| Publisher | Scholarly Repository |
| Source Sets | University of Miami |
| Detected Language | English |
| Type | text |
| Format | application/pdf |
| Source | Open Access Dissertations |
Page generated in 0.0018 seconds